Trademark: NEUROGENIX XL
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for NEUROGENIX XL
We do not have any records of a proof of use for NEUROGENIX XL at this moment.
Possible trademark infringements of NEUROGENIX XL
Basic Information about NEUROGENIX XL
- Serial Number
- 97031618
- Filing Date
- 16 Sep 2021
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of NEUROGENIX XL on the blockchain with WikiTrademarks.io.
- First use of NEUROGENIX XL anywhere
- NEUROGENIX XL was first used on 11 Jun 2020 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns NEUROGENIX XL?
1. Centinela Medical Center of South Bay Inc. Lawndale CA
Correspondent
- Centinela Medical Center of South Bay In
- 15901 Hawthorne Blvd STE 450
- Lawndale CA 90260
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io